KEHRİBAR, D. Y. Et Al. 2022. EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4 , 1355-1361.

KEHRİBAR, D. Y., Emmungil, H., BAŞAK TÜRKMEN, N., ÇİFTÇİ, O., ŞALVA, E., & Ozgen, M., (2022). EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, 1355-1361.

KEHRİBAR, DEMET Et Al. "EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, 1355-1361, 2022

KEHRİBAR, DEMET Y. Et Al. "EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, pp.1355-1361, 2022

KEHRİBAR, D. Y. Et Al. (2022) . "EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, pp.1355-1361.

@article{article, author={DEMET YALÇIN KEHRİBAR Et Al. }, title={EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2022, pages={1355-1361} }